TW201613908A - Solid forms of an ion channel modulator - Google Patents

Solid forms of an ion channel modulator

Info

Publication number
TW201613908A
TW201613908A TW104104508A TW104104508A TW201613908A TW 201613908 A TW201613908 A TW 201613908A TW 104104508 A TW104104508 A TW 104104508A TW 104104508 A TW104104508 A TW 104104508A TW 201613908 A TW201613908 A TW 201613908A
Authority
TW
Taiwan
Prior art keywords
solid forms
ion channel
channel modulator
forms
crystalline
Prior art date
Application number
TW104104508A
Other languages
English (en)
Inventor
Anna Chiu
Olga V Lapina
Petinka I Vlahova
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of TW201613908A publication Critical patent/TW201613908A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW104104508A 2014-02-13 2015-02-11 Solid forms of an ion channel modulator TW201613908A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461939640P 2014-02-13 2014-02-13

Publications (1)

Publication Number Publication Date
TW201613908A true TW201613908A (en) 2016-04-16

Family

ID=52597268

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104104508A TW201613908A (en) 2014-02-13 2015-02-11 Solid forms of an ion channel modulator

Country Status (16)

Country Link
US (1) US9273038B2 (zh)
EP (1) EP3105227A1 (zh)
JP (1) JP2017505788A (zh)
KR (1) KR20160118358A (zh)
CN (1) CN105980380A (zh)
AR (1) AR102804A1 (zh)
AU (1) AU2015217129A1 (zh)
BR (1) BR112016018464A2 (zh)
CA (1) CA2881544A1 (zh)
EA (1) EA201691360A1 (zh)
HK (1) HK1226397A1 (zh)
IL (1) IL246959A0 (zh)
MX (1) MX2016010563A (zh)
SG (1) SG11201606652PA (zh)
TW (1) TW201613908A (zh)
WO (1) WO2015123434A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI510480B (zh) 2011-05-10 2015-12-01 Gilead Sciences Inc 充當離子通道調節劑之稠合雜環化合物
NO3175985T3 (zh) 2011-07-01 2018-04-28
TW201837023A (zh) 2011-07-01 2018-10-16 美商基利科學股份有限公司 作為離子通道調節劑之稠合雜環化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4992445A (en) 1987-06-12 1991-02-12 American Cyanamid Co. Transdermal delivery of pharmaceuticals
US5001139A (en) 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
ZA200600197B (en) * 2003-07-02 2007-06-27 Vertex Pharma Pyrimidines useful as modulators of voltage-gated ion channels
AU2010276537B2 (en) * 2009-07-27 2015-04-16 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
TW201837023A (zh) 2011-07-01 2018-10-16 美商基利科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
WO2013112932A1 (en) * 2012-01-27 2013-08-01 Gilead Sciences, Inc. Combination therapies using late sodium ion channel blockers and potassium ion channel blockers

Also Published As

Publication number Publication date
CA2881544A1 (en) 2015-08-13
US20150225383A1 (en) 2015-08-13
AR102804A1 (es) 2017-03-29
CN105980380A (zh) 2016-09-28
JP2017505788A (ja) 2017-02-23
SG11201606652PA (en) 2016-09-29
MX2016010563A (es) 2016-12-12
HK1226397A1 (zh) 2017-09-29
EP3105227A1 (en) 2016-12-21
BR112016018464A2 (pt) 2017-08-08
WO2015123434A1 (en) 2015-08-20
US9273038B2 (en) 2016-03-01
EA201691360A1 (ru) 2017-07-31
AU2015217129A1 (en) 2016-08-11
IL246959A0 (en) 2016-09-29
KR20160118358A (ko) 2016-10-11

Similar Documents

Publication Publication Date Title
IL288104A (en) Heterocyclic compounds, preparation methods and their use
PH12017550028A1 (en) Solid forms of an ask1 inhibitor
MX2015011576A (es) Composiciones que comprenden compuestos de tienopirimidina y tienopiridina y metodos para usar los mismos.
PH12017502188A1 (en) Methods and compositions for inhibiting the interaction of menin with mll proteins
EP3291338A4 (en) Cathode for lithium-sulfur battery, manufacturing method therefor, and lithium-sulfur battery containing same
EP3416229A4 (en) ELECTROLYTIC SOLUTION FOR A BATTERY WITH A WATER-FREE ELECTROLYTIC SOLUTION AND A BATTERY WITH A WATER-FREE ELECTROLYTIC SOLUTION THEREWITH
EP3240089A4 (en) Sulfide-based solid electrolyte for lithium ion cell, and solid electrolyte compound
PH12016500643A1 (en) New octahydro - cyclobuta [1,2-c;3,4-c`] dipyrrol -2- yl
MY189912A (en) Substituted xanthines and methods of use thereof
EP3403292A4 (en) METHOD FOR ESTIMATING DISCHARGE DURATION DURING HIGH-SPEED BATTERY DISCHARGE
EP3276714A4 (en) Anode slurry for secondary battery for improving dispersibility and reducing resistance, and anode comprising same
EP3408814A4 (en) ESTIMATING THE LIFE OF A BATTERY
EP3511443A4 (en) POSITIVE ELECTROLYSIS OF ALKALINE WATER ELECTROLYSIS AND MANUFACTURING METHOD THEREOF
MX366765B (es) Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerósis múltiple.
EP3492469A4 (en) COMPOUND AS JAK SELECTIVE INHIBITOR, SALT THEREOF AND THERAPEUTIC USE THEREOF
EP3316379A4 (en) SOLID ELECTROLYTE AND PROCESS FOR PREPARING THE SAME, AND LITHIUM ION BATTERY CONTAINING SAME
EP3439097A4 (en) ELECTROLYTIC SOLUTION CONTAINING MAGNESIUM IONS
EP3294931A4 (en) Electrodeposited lead composition, methods of production, and uses
EP3369127A4 (en) Formation Method for Sodium Ion Cell or Battery
EP3306714A4 (en) Electrode mixture, method for manufacturing same, and secondary battery including same
EP3371845A4 (en) Electrode, battery, and method for manufacturing electrode
EP3357123A4 (en) SODIUM-METAL BATTERIES WITH INTERCALATE CATHODE
TW201613908A (en) Solid forms of an ion channel modulator
EP3083946A4 (en) Depletion of plasmacytoid dendritic cells
EP3353834A4 (en) AUTOCATALYTIC PROCESSED PLATED ANODE FOR SECONDARY BATTERY